We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Event has ended: Unfortunately you are too late to attend this event because it has already passed.

GETTING THE DEAL THROUGH: NAVIGATING ANTITRUST SCRUTINY OF HEALTH SYSTEM DEALS AND BEYOND

McDermott Will & Emery

Description

NOVEMBER 12, 2019 |Webinar

Time
12:00 – 1:00 pm ET

According to a new report by the Health Care Cost Institute, nearly three-quarters of 112 metropolitan areas across 43 states have “highly concentrated” hospital markets—showing a rise of such areas from 67% in 2012 to 72% in 2016. And in today’s regulatory environment, this trend shows no sign of deceleration as health systems grapple with reimbursement, cost and other mission critical pressures.

This M&A activity is set against a backdrop of intensive antitrust scrutiny. The Federal Trade Commission (FTC) and often state attorneys general reviews can be challenging from a time and resource perspective. Join McDermott’s healthcare antitrust team for a webinar in which they’ll discuss and offer insight on what health systems and other industry participants can do to best position their deal for review. Topics include first-hand observations on various government practices, including:

  • Greater willingness to investigate discrete individual overlapping service lines and increasingly narrow geographic areas;
  • Growing reliance on econometric tools and economic analysis in their reviews;
  • Analytical approach toward markets where narrow and tiered networks are on the rise; and
  • Assessment of how local ACOs or CINs may factor into competitive effects analysis of a health system merger.

 

 

Details

Date
12 November 2019
Location
Webinar